secwatch.observer — SEC 8-K summary
======================================

Issuer:     Progyny, Inc. (PGNY)
CIK:        0001551306
Form:       8-K/A
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001551306-25-000025
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Progyny reports Q4 revenue $298.4M (+10.6% YoY); FY2025 guidance $1.175-1.225B; corrects 2025 ART cycle outlook
--------------------------------------------------------------------------------

- Q4 2024 revenue $298.4M (+10.6% YoY); net income $10.5M ($0.12 EPS); Adj. EBITDA $47.5M (15.9% margin).
- FY2024 revenue $1.167B (+7.2%); net income $54.3M ($0.57 EPS); Adj. EBITDA $198.8M (17.0% margin).
- FY2025 guidance: revenue $1.175-1.225B; Adj. EBITDA $188-201M; Adj. EPS $1.52-1.62.
- Correction: 2025 ART cycle guidance revised to 61,600-64,300 from 59,350-61,850; no change to financial guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551306/000155130625000025/0001551306-25-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551306/000155130625000025/pgny-20250227.htm
  HTML page:      https://secwatch.observer/filing/0001551306-25-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer